April 2016

After several delays the FDA has finally released its draft guidance that says a biosimilar's label does not have to be…

Yesterday the FDA approved Inflectra the Pfizer/Celltrion version of Remicade, becoming the second biosimilar and the…

The Medicare Payment Advisory Commission held a meeting on Part B drug payment policy issues. The meeting focused on the…

Bain & Company, Inc. has published their Front Line of Healthcare Report 2015, a report that focuses on the shifting…

We have previously written about the 2020 Task Force organized by the American Board of Internal Medicine (ABIM) on…

According to HHS, a backlog exists of more than 800,000 appeals from health care providers challenging denied Medicare…

Spinoff's, Mergers and Acquisitions abound in the life science compliance firm. One firm Streebo the creators of Open…

The American Enterprise Institute recently published a research publication on specialty drug pricing. The publication,…

The idea that doctors are promoting treatments on social media has gotten some attention from media outlets over the…